C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 243/14 (2006.01) A61K 31/5513 (2006.01) A61P 19/02 (2006.01) A61P 35/00 (2006.01) C07D 401/06 (2006.01) C07D 405/06 (2006.01) C07D 409/06 (2006.01) C07D 521/00 (2006.01)
Patent
CA 2356267
Compounds having formula (1) are useful in treating disease conditions mediated by matrix metalloproteinases and TACE, such as tumor growth, osteoarthritis, rheumatoid arthritis and degenerative cartilage loss.
L'invention concerne des composés, représentés par la formule (1) ci-après, qui sont utiles dans le cadre du traitement des états pathologiques induits par des métalloprotéinases matricielles et l'enzyme TACE, notamment la croissance tumorale, l'arthrose et la perte de cartilage dégénérative.
Albright Jay Donald
Chen James Ming
Delos Santos Efren Guillermo
Levin Jeremy Ian
American Cyanamid Company
Torys Llp
Wyeth Holdings Corporation
LandOfFree
2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2,3,4,5-tetrahydro-1h-¬1,4|benzodiazepine-3-hydroxamic acid... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1527475